Treatment Registry
TR-0576 ActiveRecorded September 2026

Brand tirzepatide

Sold by Rex MD · Injection, vial · every brand tirzepatide record

Recorded initial charges

First month

$424

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Zepbound, cash-pay via Eli Lilly direct · recorded initial monthly payment$349
Required membership · Monthly membership$75

Added from the figures recorded below.

Price

TermPer monthCharged today
Zepbound, cash-pay via Eli Lilly direct

“Zepbound® is available in two forms: vials or pens. The vial is available directly through manufacturer Eli Lilly, starting at $349 per month, cash-pay.”

Per month$349Charged today$349
Price sources
Visit Rex MD

We earn nothing from this link. It opens Rex MD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberBoth
CancellationWe offer the flexibility to pause or cancel your subscription at any time. Simply reach out to our customer Care Team at 1-866-294-3772, [email protected], or through your patient portal to make any changes to your account.
MembershipRequired. $75 per month. The Rex MD Weight Management Program starts at $75, with the flexibility to cancel anytime. Our comprehensive program includes expert clinician consultations, personalized prescriptions, dedicated coaching, and essential lab work (if you haven't completed the required tests within the last 12 months).

Not yet checked: pharmacy and consult fee.

Recorded from rexmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0576
Medication category
brand tirzepatide
Readings
1

Related records

Other records from Rex MD

All Rex MD programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 101 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Rex MD — brand tirzepatide (TR-0576). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0576

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.